You can now read 10 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe


Ariad readies for launch of first cancer treatment

The company is focusing on sales — along with science — as its promising first therapy awaits approval

CAMBRIDGE — Ariad Pharmaceuticals Inc. has spent two decades in classic biotechnology start-up mode. Company scientists have labored at designing drugs and identifying diseases to target, while its investors have waited for Ariad’s first product to hit the market.

Some time soon, the perseverance may finally pay off.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week